Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 91

1.

Physical and functional interactions between PML and MDM2.

Wei X, Yu ZK, Ramalingam A, Grossman SR, Yu JH, Bloch DB, Maki CG.

J Biol Chem. 2003 Aug 1;278(31):29288-97. Epub 2003 May 19.

2.

Polyubiquitination of p53 by a ubiquitin ligase activity of p300.

Grossman SR, Deato ME, Brignone C, Chan HM, Kung AL, Tagami H, Nakatani Y, Livingston DM.

Science. 2003 Apr 11;300(5617):342-4.

3.

Tumor suppression by Ink4a-Arf: progress and puzzles.

Lowe SW, Sherr CJ.

Curr Opin Genet Dev. 2003 Feb;13(1):77-83. Review.

PMID:
12573439
4.

Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies.

Borden KL.

Mol Cell Biol. 2002 Aug;22(15):5259-69. Review. No abstract available.

5.

A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy.

Schmitt CA, Fridman JS, Yang M, Lee S, Baranov E, Hoffman RM, Lowe SW.

Cell. 2002 May 3;109(3):335-46.

6.

Mutual dependence of MDM2 and MDMX in their functional inactivation of p53.

Gu J, Kawai H, Nie L, Kitao H, Wiederschain D, Jochemsen AG, Parant J, Lozano G, Yuan ZM.

J Biol Chem. 2002 May 31;277(22):19251-4. Epub 2002 Apr 12.

7.

p63 and p73 are required for p53-dependent apoptosis in response to DNA damage.

Flores ER, Tsai KY, Crowley D, Sengupta S, Yang A, McKeon F, Jacks T.

Nature. 2002 Apr 4;416(6880):560-4.

PMID:
11932750
8.

The role of PML in tumor suppression.

Salomoni P, Pandolfi PP.

Cell. 2002 Jan 25;108(2):165-70. Review.

9.

Ubiquitin-mediated degradation of cellular proteins in health and disease.

Ciechanover A, Schwartz AL.

Hepatology. 2002 Jan;35(1):3-6. Review. No abstract available.

PMID:
11786953
10.

Function and dysfunction of the human oncoprotein MDM2.

Deb SP.

Front Biosci. 2002 Jan 1;7:d235-43. Review.

PMID:
11779693
11.

Identification of p53 sequence elements that are required for MDM2-mediated nuclear export.

Gu J, Nie L, Wiederschain D, Yuan ZM.

Mol Cell Biol. 2001 Dec;21(24):8533-46.

12.

C-terminal ubiquitination of p53 contributes to nuclear export.

Lohrum MA, Woods DB, Ludwig RL, Bálint E, Vousden KH.

Mol Cell Biol. 2001 Dec;21(24):8521-32.

13.

PML interaction with p53 and its role in apoptosis and replicative senescence.

Pearson M, Pelicci PG.

Oncogene. 2001 Oct 29;20(49):7250-6. Review.

14.

Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.

Parant J, Chavez-Reyes A, Little NA, Yan W, Reinke V, Jochemsen AG, Lozano G.

Nat Genet. 2001 Sep;29(1):92-5.

PMID:
11528400
15.

An alternatively spliced HDM2 product increases p53 activity by inhibiting HDM2.

Evans SC, Viswanathan M, Grier JD, Narayana M, El-Naggar AK, Lozano G.

Oncogene. 2001 Jul 5;20(30):4041-9.

16.

MDM2: life without p53.

Daujat S, Neel H, Piette J.

Trends Genet. 2001 Aug;17(8):459-64. Review.

PMID:
11485818
17.

p73.

Davis PK, Dowdy SF.

Int J Biochem Cell Biol. 2001 Oct;33(10):935-9. Review.

PMID:
11470228
18.
19.

Human mdm2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerization.

Lai Z, Ferry KV, Diamond MA, Wee KE, Kim YB, Ma J, Yang T, Benfield PA, Copeland RA, Auger KR.

J Biol Chem. 2001 Aug 17;276(33):31357-67. Epub 2001 Jun 7.

20.

p300/CBP/p53 interaction and regulation of the p53 response.

Grossman SR.

Eur J Biochem. 2001 May;268(10):2773-8. Review.

Supplemental Content

Support Center